US Stock MarketDetailed Quotes

XTLB XTL Biopharmaceuticals

Watchlist

2.610
+0.030+1.16%

Close May 24 16:00 ET

2.780
+0.170+6.51%

Post 17:31 ET

14.22MMarket Cap-84193P/E (TTM)

XTL Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

(FY)Dec 31, 2019

(FY)Dec 31, 2018

(FY)Dec 31, 2017

(FY)Dec 31, 2016

(Q2)Jun 30, 2016

(FY)Dec 31, 2015

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

21.53%-707K

14.11%-901K

-23.41%-1.05M

6.39%-850K

-11.27%-908K

27.47%-816K

35.05%-1.13M

6.93%-1.73M

1.17%-508K

24.66%-1.86M

Net income from continuing operations

-32.20%-1.78M

-409.89%-1.35M

114.73%435K

-287.16%-2.95M

-121.02%-763K

564.79%3.63M

69.31%-781K

40.96%-2.55M

-11.71%-477K

-50.47%-4.31M

Operating gains losses

102.59%27K

-46.42%-1.04M

-134.95%-713K

29,242.86%2.04M

99.84%-7K

-480.24%-4.38M

-25,233.33%-754K

-99.57%3K

91.67%-3K

349.36%701K

Depreciation and amortization

--0

0.00%1K

--1K

--0

----

-50.00%1K

-86.79%7K

Other non cash items

-13.89%-41K

-350.00%-36K

75.76%-8K

64.52%-33K

-6.90%-93K

-127.36%-87K

--318K

----

--6K

Change In working capital

436.84%64K

64.81%-19K

-220.00%-54K

190.00%45K

-525.00%-50K

-115.38%-8K

123.64%52K

-1,275.00%-220K

-74.24%-115K

89.61%-16K

-Change in receivables

----

-416.67%-114K

-101.92%-1K

150.00%36K

-Change in prepaid assets

80.00%45K

180.65%25K

-234.78%-31K

179.31%23K

-174.36%-29K

-81.34%39K

--209K

----

-Change in payables and accrued expense

143.18%19K

-91.30%-44K

-204.55%-23K

204.76%22K

55.32%-21K

70.06%-47K

-48.11%-157K

-103.85%-106K

3.39%-114K

81.29%-52K

Cash from discontinued investing activities

Operating cash flow

21.53%-707K

14.11%-901K

-23.41%-1.05M

6.39%-850K

-11.27%-908K

27.47%-816K

35.05%-1.13M

6.93%-1.73M

1.17%-508K

24.66%-1.86M

Investing cash flow

Cash flow from continuing investing activities

13.89%41K

350.00%36K

-75.00%8K

-98.48%32K

171.34%2.11M

131.18%778K

-3,680.30%-2.5M

40.00%-66K

107.14%1K

-107.34%-110K

Net PPE purchase and sale

----

50.00%-1K

---2K

--0

150.00%1K

0.00%-2K

----

75.00%-2K

Net intangibles purchase and sale

----

0.00%-64K

----

-3,100.00%-64K

Net business purchase and sale

----

---55K

Net investment purchase and sale

----

186.93%2.02M

128.16%704K

---2.5M

--0

----

--0

Net other investing changes

----

108.33%1K

450.00%11K

Cash from discontinued investing activities

Investing cash flow

13.89%41K

350.00%36K

-75.00%8K

-98.48%32K

171.34%2.11M

131.18%778K

-3,680.30%-2.5M

40.00%-66K

107.14%1K

-107.34%-110K

Financing cash flow

Cash flow from continuing financing activities

385K

4.89M

1,058.25%3.58M

Net common stock issuance

----

--4.89M

--0

----

1,051.78%3.56M

Proceeds from stock option exercised by employees

--0

--385K

--0

----

Net other financing activities

----

--20K

Cash from discontinued financing activities

Financing cash flow

--0

--385K

--0

----

--4.89M

--0

----

1,058.25%3.58M

Net cash flow

Beginning cash position

-29.47%2.09M

-18.23%2.97M

-18.50%3.63M

36.87%4.46M

-1.03%3.26M

62.90%3.29M

-47.11%2.02M

76.79%3.82M

77.35%3.11M

-25.22%2.16M

Current changes in cash

23.01%-666K

-31.86%-865K

19.80%-656K

-168.00%-818K

3,265.79%1.2M

-102.99%-38K

170.75%1.27M

-211.82%-1.8M

-116.73%-507K

342.90%1.61M

Effect of exchange rate changes

-170.00%-27K

-66.67%-10K

0.00%-6K

-100.00%-6K

-175.00%-3K

300.00%4K

---2K

----

-91.67%3K

85.71%-2K

End cash Position

-33.09%1.4M

-29.47%2.09M

-18.23%2.97M

-18.50%3.63M

36.87%4.46M

-1.03%3.26M

62.90%3.29M

-47.11%2.02M

-45.95%2.61M

76.79%3.82M

Free cash flow

21.53%-707K

14.11%-901K

-23.27%-1.05M

6.48%-851K

-11.52%-910K

27.47%-816K

37.43%-1.13M

6.69%-1.8M

1.55%-508K

22.30%-1.93M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020	(FY)Dec 31, 2019	(FY)Dec 31, 2018	(FY)Dec 31, 2017	(FY)Dec 31, 2016	(Q2)Jun 30, 2016	(FY)Dec 31, 2015
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	21.53%-707K	14.11%-901K	-23.41%-1.05M	6.39%-850K	-11.27%-908K	27.47%-816K	35.05%-1.13M	6.93%-1.73M	1.17%-508K	24.66%-1.86M
Net income from continuing operations	-32.20%-1.78M	-409.89%-1.35M	114.73%435K	-287.16%-2.95M	-121.02%-763K	564.79%3.63M	69.31%-781K	40.96%-2.55M	-11.71%-477K	-50.47%-4.31M
Operating gains losses	102.59%27K	-46.42%-1.04M	-134.95%-713K	29,242.86%2.04M	99.84%-7K	-480.24%-4.38M	-25,233.33%-754K	-99.57%3K	91.67%-3K	349.36%701K
Depreciation and amortization	--0	0.00%1K	0.00%1K	--1K	--0	--0	--0	----	-50.00%1K	-86.79%7K
Other non cash items	-13.89%-41K	-350.00%-36K	75.76%-8K	64.52%-33K	-6.90%-93K	-127.36%-87K	--318K	----	----	--6K
Change In working capital	436.84%64K	64.81%-19K	-220.00%-54K	190.00%45K	-525.00%-50K	-115.38%-8K	123.64%52K	-1,275.00%-220K	-74.24%-115K	89.61%-16K
-Change in receivables	----	----	----	----	----	----	----	-416.67%-114K	-101.92%-1K	150.00%36K
-Change in prepaid assets	80.00%45K	180.65%25K	-234.78%-31K	179.31%23K	-174.36%-29K	-81.34%39K	--209K	----	----	----
-Change in payables and accrued expense	143.18%19K	-91.30%-44K	-204.55%-23K	204.76%22K	55.32%-21K	70.06%-47K	-48.11%-157K	-103.85%-106K	3.39%-114K	81.29%-52K
Cash from discontinued investing activities
Operating cash flow	21.53%-707K	14.11%-901K	-23.41%-1.05M	6.39%-850K	-11.27%-908K	27.47%-816K	35.05%-1.13M	6.93%-1.73M	1.17%-508K	24.66%-1.86M
Investing cash flow
Cash flow from continuing investing activities	13.89%41K	350.00%36K	-75.00%8K	-98.48%32K	171.34%2.11M	131.18%778K	-3,680.30%-2.5M	40.00%-66K	107.14%1K	-107.34%-110K
Net PPE purchase and sale	----	----	----	50.00%-1K	---2K	--0	150.00%1K	0.00%-2K	----	75.00%-2K
Net intangibles purchase and sale	----	----	----	----	----	----	----	0.00%-64K	----	-3,100.00%-64K
Net business purchase and sale	----	----	----	----	----	----	----	----	----	---55K
Net investment purchase and sale	----	----	----	----	186.93%2.02M	128.16%704K	---2.5M	--0	----	--0
Net other investing changes	----	----	----	----	----	----	----	----	108.33%1K	450.00%11K
Cash from discontinued investing activities
Investing cash flow	13.89%41K	350.00%36K	-75.00%8K	-98.48%32K	171.34%2.11M	131.18%778K	-3,680.30%-2.5M	40.00%-66K	107.14%1K	-107.34%-110K
Financing cash flow
Cash flow from continuing financing activities	0	0	385K	0	0		4.89M	0		1,058.25%3.58M
Net common stock issuance	----	----	----	----	----	----	--4.89M	--0	----	1,051.78%3.56M
Proceeds from stock option exercised by employees	--0	--0	--385K	--0	--0	----	----	----	----	----
Net other financing activities	----	----	----	----	----	----	----	----	----	--20K
Cash from discontinued financing activities
Financing cash flow	--0	--0	--385K	--0	--0	----	--4.89M	--0	----	1,058.25%3.58M
Net cash flow
Beginning cash position	-29.47%2.09M	-18.23%2.97M	-18.50%3.63M	36.87%4.46M	-1.03%3.26M	62.90%3.29M	-47.11%2.02M	76.79%3.82M	77.35%3.11M	-25.22%2.16M
Current changes in cash	23.01%-666K	-31.86%-865K	19.80%-656K	-168.00%-818K	3,265.79%1.2M	-102.99%-38K	170.75%1.27M	-211.82%-1.8M	-116.73%-507K	342.90%1.61M
Effect of exchange rate changes	-170.00%-27K	-66.67%-10K	0.00%-6K	-100.00%-6K	-175.00%-3K	300.00%4K	---2K	----	-91.67%3K	85.71%-2K
End cash Position	-33.09%1.4M	-29.47%2.09M	-18.23%2.97M	-18.50%3.63M	36.87%4.46M	-1.03%3.26M	62.90%3.29M	-47.11%2.02M	-45.95%2.61M	76.79%3.82M
Free cash flow	21.53%-707K	14.11%-901K	-23.27%-1.05M	6.48%-851K	-11.52%-910K	27.47%-816K	37.43%-1.13M	6.69%-1.8M	1.55%-508K	22.30%-1.93M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall